News archives


OCTOBER - DECEMBER 17

JULY - SEPTEMBER 17

APRIL - JUNE 17

JANUARY - MARCH 17

OCTOBER - DECEMBER 16

JULY - SEPTEMBER 16

APRIL - JUNE 16

JANUARY - MARCH 16

OCTOBER - DECEMBER 15

JULY - SEPTEMBER 15

APRIL - JUNE 15

JANUARY - MARCH 15

OCTOBER - DECEMBER 14

JULY - SEPTEMBER 14

APRIL - JUNE 14

JANUARY - MARCH 14

OCTOBER - DECEMBER 13

JULY - SEPTEMBER 13

APRIL - JUNE 13

JANUARY - MARCH 13

OCTOBER - DECEMBER 12

JULY - SEPTEMBER 12

APRIL - JUNE 12

JANUARY - MARCH 12

OCTOBER - DECEMBER 11

JULY - SEPTEMBER 11

APRIL - JUNE 11

JANUARY - MARCH 11

OCTOBER - DECEMBER 10

JULY - SEPTEMBER 10

APRIL - JUNE 10

JANUARY - MARCH 10

OCTOBER - DECEMBER 09

JULY - SEPTEMBER 09

APRIL - JUNE 09

JANUARY - MARCH 09

OCTOBER - DECEMBER 08

JULY - SEPTEMBER 08

APRIL - JUNE 08

JANUARY - MARCH 08

OCTOBER - DECEMBER 07

JULY - SEPTEMBER 07

APRIL - JUNE 07

JANUARY - MARCH 07

 
  current news   Press   selected story    
     
  25 May 2017  
 
Congratulations to IMCB's recent PhD graduate
 
 




Thesis titleCharacterisation of novel bacterial filament systems and their potential as antibiotic targets.

Supervisor: Robert ROBINSON

Abstract
Bacterial actin-like filament systems (such as ParM and MreB) are needed to carry out essential functions such as cell shape maintenance and plasmid segregation. The aim of the studying bacterial filaments is to understand their biological roles and to assess their potential as novel antibacterial drug targets. First, novel proteins Cb40 ParM and Cb20 ParM were found to assemble into distinct organisations with different sets of structural properties, suggesting that they may have dissimilar mechanisms for DNA segregation. Next, novel MreB-like protein TmMblwas found to be a potential modulator of TmMreB activity in the bacteria T. Maritima and it is likely to assist TmMreB in its cellular functions. Lastly, MreB inhibitors A22 and Mp265 were characterised, they induce MreB depolymerisation by causing conformational changes into its monomeric state. In conclusion, bacterial actin-like proteins (Alp) are great potential targets for a new class of antibiotic, but more work is needed to obtain better Alp perturbing compounds.

Figure legend:
(A) TmMreB colocalised with TmMbl in vitro and formed bundles.
(B) MreB inhibitor Mp265 depolymerised TmMreB and TmMbl bundles.

List of publications:
Microtubule-like properties of the bacterial actin homolog ParM-R1.
Popp D, Narita A, Lee LJ, Larsson M, Robinson RC.
J Biol Chem. 2012 Oct 26;287(44):37078-88. doi: 10.1074/jbc.M111.319491. Epub 2012 Aug 20.

Novel actin-like filament structure from Clostridium tetani.
Popp D, Narita A, Lee LJ, Ghoshdastider U, Xue B, Srinivasan R, Balasubramanian MK, Tanaka T, Robinson RC.
J Biol Chem. 2012 Jun 15;287(25):21121-9. doi: 10.1074/jbc.M112.341016. Epub 2012 Apr 18.

Novel actin filaments from Bacillus thuringiensis form nanotubules for plasmid DNA segregation.
Jiang SM, Narita A, Popp D, Ghoshdastider U, Lee LJ, Srinivasan R,. Balasubramanian M, Oda T, Koh FJ, Larsson M, and Robinson RC.
PNA.S 2016Mar1;113(9):E1200–E1205,doi:10.1073/pnas.1600129113

For more information on Robert ROBINSON's lab, please click here.